In vivo modulation of glucocorticoid receptor mRNA by inhaled fluticasone propionate in bronchial mucosa and blood lymphocytes in subjects with mild asthma
O. Andersson et al., In vivo modulation of glucocorticoid receptor mRNA by inhaled fluticasone propionate in bronchial mucosa and blood lymphocytes in subjects with mild asthma, J ALLERG CL, 103(4), 1999, pp. 595-600
Background: In vivo regulation of the glucocorticoid receptor (GR) by gluco
corticoids provides a means of modulating sensitivity of targeted cells.
Objective: We sought to determine the in vivo modulation of GR mRNA express
ion by fluticasone propionate (FP) in subjects with mild asthma.
Methods: Ten atopic asthmatic subjects were treated with FP 250 mu g twice
daily for 4 weeks. Before and after treatment, the patients underwent fiber
optic bronchoscopy with endobronchial biopsy and sampling of venous blood f
or measurements of GR mRNA levels, A solution hybridization assay was used
for quantitative analysis of GR mRNA. In addition, a 24-hour urinary cortis
ol excretion and an adrenocorticotropic hormone test before and after treat
ment with FP were performed.
Results: A high interindividual variation in GR mRNA expression was seen. H
owever, we detected a significant reduction of the GR mRNA levels in the en
dobronchial biopsy specimens after FP treatment (36.6 +/- 23.1 and 25.0 +/-
10.9 amol GR mRNA/mu g RNA, respectively; P < .01). In the peripheral bloo
d lymphocytes an even more striking downregulation of the GR by its cognate
ligand was documented (30.3 +/- 26.5 and 8.8 +/- 5 amol GR mRNA/mu g RNA,
respectively; P < .001), possibly reflecting differences in glucocorticoid
sensitivity between tissues. A small but significant reduction of the 24-ho
ur urinary cortisol excretion was observed (233 +/- 109 and 157 +/- 66 nmol
/L, respectively; P < .01), whereas the feedback regulation of glucocortico
id synthesis by means of the hypothalamic-pituitary-adrenal axis as assesse
d by the adrenocorticotropic hormone test remained normal after treatment w
ith FP.
Conclusion: The results in this study confirm the potency of the inhaled co
rticosteroid FP and provide evidence for a considerable tissue-specific int
erindividual variation in the expression of the GR.